MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Clinical trials for MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY trials appear
Sign up with your email to follow new studies for MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a fatty acid drug stop dangerous blood sugar drops in MCADD?
Disease control Recruiting nowThis study tests a drug called triheptanoin in 24 people aged 4 and older with MCADD, a rare genetic condition that can cause dangerously low blood sugar. The drug is already approved for similar disorders and may help keep glucose levels stable. Researchers will monitor safety a…
Matched conditions: MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Fatty acid study aims to unlock MCADD mysteries
Knowledge-focused Recruiting nowThis study looks at how medium-chain and long-chain fatty acids affect metabolism in people with MCADD (a rare genetic disorder) and healthy volunteers. Researchers will measure ketone bodies and resting metabolic rate after fat intake. The goal is to better understand the body's…
Matched conditions: MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Phase: NA • Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated May 26, 2026 06:09 UTC